Prøve GULL - Gratis
BEL faces lofty valuation test
Mint New Delhi
|November 05, 2025
Bharat Electronics Ltd's (BEL) investors are a happy lot.
The shares are up about 40% so far in 2025. Strong Septemberquarter (Q2FY26) results and healthy near-term prospects show it could continue to find support.
Robust execution lifted BEL's Q2 revenue by 26% year-on-year to ₹5,764 crore. While the Ebitda margin contracted nearly 90 basis points to 29.4%, it was still ahead of analysts' expectations. The defence electronics company has maintained its FY26 guidance of 15% revenue growth and a 27% Ebitda margin, after a solid performance in first half of the year that saw 16% revenue growth and a 28.8% margin.
The company's Q2 order book is at ₹74,500 crore, which while flattish yo-y, offers strong visibility as it is three times trailing 12 months' revenue. Order inflows rose a whopping 117% yo-y to ₹5,360 crore.
Denne historien er fra November 05, 2025-utgaven av Mint New Delhi.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint New Delhi
Mint New Delhi
Aakash CFO Vipan Joshi quits as leadership churn deepens
Vipan Joshi, chief financial officer at Aakash Educational Services Ltd, has resigned effective 31 October, two people aware of the development said, adding to a leadership churn as the company proceeds with a rights issue.
2 mins
November 05, 2025
Mint New Delhi
The CEO behind Kimberly-Clark's $40 billion gamble on Tylenol maker
Mike Hsu aims to stoke the consumer company's growth by veering into Kenvue's higher-margin but risky health products
5 mins
November 05, 2025
Mint New Delhi
BEL faces lofty valuation test
Bharat Electronics Ltd's (BEL) investors are a happy lot.
2 mins
November 05, 2025
Mint New Delhi
Ambuja’s plan to spur market share will be a tightrope walk
Ambuja Cements Ltd is chasing both volume growth and operational efficiencies.
1 mins
November 05, 2025
Mint New Delhi
Serum’s new TB vaccine denied approval
India's top drug regulator has denied approval for Serum Institute of India Pvt. Ltd.'s new tuberculosis vaccine, calling the test data \"not adequate and conclusive\", according to a document and two government officials familiar with the matter.
2 mins
November 05, 2025
Mint New Delhi
State Street in talks for Indian MF stake
State Street Investment Management is in talks to acquire a stake in an Indian mutual fund as it seeks to tap into the nation’s $900 billion asset management industry, according to a person familiar with the matter.
1 min
November 05, 2025
Mint New Delhi
She designed Taylor Swift’s engagement ring. Business is booming.
Kindred Lubeck was sitting in the studio in 2020, working on a silver piece, when the jewelry maker sitting next to her asked, \"So, what do you want to do with this?
4 mins
November 05, 2025
Mint New Delhi
Tractors boost Mahindra’s Q2 earnings
A surge in tractor sales boosted the July-September earnings for Mahindra and Mahindra Ltd (M&M), which saw a slowdown in demand for its sport utility vehicles (SUVs) as consumers delayed purchases in anticipation of goods and services tax (GST) cuts.
2 mins
November 05, 2025
Mint New Delhi
When there's no will, there's no way home for your legacy
Wills ensure your assets are distributed as you wish; don't let the law decide your family’s fate
4 mins
November 05, 2025
Mint New Delhi
Export headwinds: Can services ride them out?
Weak merchandise exports to the US aren't a surprise, but service exports have slumped too. However, India's 'de facto exports' could rise even as direct earnings from service exports fall
2 mins
November 05, 2025
Listen
Translate
Change font size